Patent · US Active

CRISPR enabled multiplexed genome engineering

US10351877B2 · kind B2 · utility

18Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 9, 2018
Grant dateJul 16, 2019
Priority date
Expiry dateApr 9, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/31
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described herein are methods and vectors for rational, multiplexed manipulation of chromosomes within open reading frames (e.g., in protein libraries) or any segment of a chromosome in a cell or population of cells, in which various CRISPR systems are used.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.